Why people quit TRT: separating real side effects from TikTok drama

What did @dorkbait actually say?

They listed five reasons for stopping testosterone gel as a trans man: hair thinning despite finasteride use, worsened joint pain from pre-existing arthritis, increased aggression affecting mood and relationships, social safety concerns, and a shifting sense of gender identity toward non-binary. These are personal reasons, not medical advice, and they were upfront about that distinction. Worth noting: they were already on finasteride before starting T, which matters clinically.

The framing is honest. They said "whether that's testosterone or stress, I don't know" about the hair loss, which is exactly the kind of epistemic humility you rarely get on TikTok. They also acknowledged knowing in advance that T could worsen existing joint symptoms. This isn't someone making wild medical claims. It's a person documenting their own discontinuation experience, which is actually useful data that the clinical literature underrepresents.

Does the science back this up?

On balance, yes, the physiological claims hold up reasonably well. Testosterone's role in androgenetic alopecia, joint inflammation, and mood dysregulation in certain populations is documented, though the effect sizes and mechanisms are more complicated than a TikTok can capture.

Hair loss: Testosterone converts to dihydrotestosterone (DHT) via 5-alpha reductase. DHT is the primary driver of androgenetic alopecia in genetically susceptible individuals. Finasteride blocks this conversion, but it doesn't eliminate DHT entirely, and some people have follicles that respond to even low DHT levels. A 2019 study by Irwig in the journal Andrology confirmed androgenetic alopecia as a common concern in trans men on testosterone. Being on finasteride from the start was clinically sound, but it's not a guaranteed shield.

Joint pain: The relationship between testosterone and joint inflammation is genuinely complex. Testosterone has both pro- and anti-inflammatory properties depending on the tissue and hormonal context. A 2021 review by Yassin et al. in The Aging Male found that testosterone therapy in hypogonadal men sometimes improved inflammatory markers, but baseline inflammatory conditions like rheumatoid arthritis could respond unpredictably. The creator's experience of worsening wrist arthritis is plausible and documented in case literature, even if it isn't the modal outcome.

Mood and aggression: This is where it gets complicated. See below.

What did they get wrong (or right)?

They got the hair and joint stuff mostly right. The mood claim deserves more scrutiny, though not because they're wrong that T affected them, but because the mechanism they implied is oversimplified.

The claim that testosterone causes aggression is one of the most overstated ideas in popular endocrinology. A 2021 meta-analysis by van der Loos et al. in Psychoneuroendocrinology found that testosterone's effect on aggression in trans men was modest and inconsistent across studies. What the research does support is that exogenous testosterone can amplify emotional reactivity in people with pre-existing mood dysregulation, particularly in the early months of therapy before levels stabilize. The creator identifies as Cluster B and AUDHD, both of which involve nervous system differences that can interact with hormonal shifts in meaningful ways. Their experience is real. The framing of T as simply making people "more aggressive" is less accurate than saying T can destabilize mood regulation in susceptible individuals during the adjustment period.

The finasteride-plus-testosterone combination they were using is clinically recognized and not a concerning stack. No issues there.

What should you actually know?

Discontinuation of gender-affirming hormone therapy is more common than clinical studies reflect, partly because people who stop often disappear from follow-up cohorts. A 2021 cohort study by Wiepjes et al. in The Journal of Sexual Medicine found discontinuation rates around 11 percent over a median follow-up of several years, with side effects and identity evolution both cited as reasons. This creator's experience is not unusual.

If you're on T and experiencing joint pain, mood changes, or hair loss, these are not signs you need to push through. They are clinical signals worth discussing with a prescriber. Dose adjustments, delivery method changes, or adjunct medications may address specific side effects without requiring full discontinuation. Testosterone gel has different absorption variability than injectable forms, and that variability can contribute to mood instability in some people.

Identity changes during or after hormone therapy are also documented and normal. The creator's shift toward non-binary identification is not a clinical red flag. It is a human experience that medicine is slowly getting better at accommodating.

Is there anything the video missed?

Yes. The creator doesn't mention what their testosterone levels were when they stopped, which is clinically relevant. If levels weren't in range to begin with, some of these side effects could reflect supraphysiologic dosing rather than an inherent problem with T therapy. Gel formulations are notoriously variable in absorption. A person experiencing mood instability and worsening inflammation on gel might respond differently to a different delivery method or a lower stabilized dose. That conversation apparently never happened, or wasn't mentioned. That's a gap worth flagging, not to dismiss their decision, but because options existed that may not have been explored.